"Advancing syndromic surveillance practice by leveraging the expertise and resources of members to strengthen public health surveillance capabilities nationwide."

2022 Syndromic Surveillance Symposium
December 6-8, 2022

The Council of State and Territorial Epidemiologists (CSTE), in collaboration with the Centers for Disease Control and Prevention’s (CDC) National Syndromic Surveillance Program (NSSP), will VIRTUALLY convene the 2022 Syndromic Surveillance Symposium on December 6-8, 2022 from 12:45-5pm ET on 12/6 and 12/7 and from 12:45-3:30pm ET on 12/8.

The 2022 Syndromic Surveillance Symposium’s schedule will offer many opportunities to exchange ideas with colleagues through trainings, presentations, and informal breaks. Please explore the agenda for the Symposium here.

The event is open to any person or organization interested in advancing SyS practice and is FREE of charge. However, the target audience for this event is syndromic surveillance coordinators and practitioners, applied epidemiologists, ELC HIS cooperative agreement leads, and NSSP site administrators.

Please reach out to the CSTE National Office at syndromic@cste.org for any questions regarding the Symposium.

About Our Community

Learn more about the National Syndromic Surveillance Program (NSSP), the NSSP Community of Practice (CoP), the CoP’s vision and mission, benefits of CoP participation, and how to get involved.

Join the NSSP CoP, check out the opportunities for community engagement, learn about different NSSP CoP-related groups, and review the monthly call calendar.


Check out the NSSP CoP Calendar for information on future NSSP CoP-related events, monthly meetings, and ad hoc calls.

NSSP Community of Practice Spotlight

Hear how the CoP and its members are advancing syndromic surveillance practice by strengthening public health surveillance capabilities nationwide.

Find the NSSP CoP Knowledge Repository, technical syndromic surveillance resources for your day-to-day practice, and syndromic surveillance programs across the nation.